Summit Therapeutics Inc (SMMT)

Apr 15, 2025

Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Apr 15, 2025

Apr 15, 2025

Why Summit Therapeutics Inc. (SMMT) Skyrocketed On Monday? - MSN

Apr 15, 2025

Apr 14, 2025

U.S. Indexes Rose Monday; Summit Therapeutics Led Increases - Barron's

Apr 14, 2025

Apr 14, 2025

Here's Why Summit Therapeutics Stock Soared 15% on Friday - MSN

Apr 14, 2025

Apr 14, 2025

Summit Therapeutics (NasdaqGM:SMMT) Welcomes Robert LaCaze As New Chief Commercial Officer - Yahoo Finance

Apr 14, 2025

Apr 14, 2025

Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition (SMMT) - Seeking Alpha

Apr 14, 2025

Apr 14, 2025

Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX - MSN

Apr 14, 2025

Apr 13, 2025

Gold Related Large-Cap Stocks Outperformed In One Of The Most Volatile Weeks (Apr 7-Apr 11): Are These In Your Portfolio? - Benzinga

Apr 13, 2025

Apr 12, 2025

Why Summit Therapeutics Inc. (SMMT) Soared Last Week? - Insider Monkey

Apr 12, 2025

Apr 12, 2025

10 Firms Defy Market Slump, Record Double-Digit Gains Last Week - Insider Monkey

Apr 12, 2025

Apr 12, 2025

3 Magnificent Stocks That Could Double or More by 2030 - Yahoo Finance

Apr 12, 2025

Apr 12, 2025

Summit Therapeutics spikes after co-CEO’s early warrants exercise - MSN

Apr 12, 2025

Apr 12, 2025

Summit Therapeutics: Not Pharmacyclics, Not Yet - Seeking Alpha

Apr 12, 2025

Apr 12, 2025

Why Summit Therapeutics Inc. (SMMT) Surged On Friday? - MSN

Apr 12, 2025

Apr 11, 2025

Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks - Insider Monkey

Apr 11, 2025

Apr 11, 2025

U.S. Indexes Moved Upward Friday; Summit Therapeutics Led Increases - Barron's

Apr 11, 2025

Apr 11, 2025

Summit co-CEO option exercise ‘quite bullish,’ says Cantor Fitzgerald - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Expert says Summit’s HARMONi-2 study could beat expectations, says Truist - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Summit Therapeutics (SMMT) Grants Stock Options to New Employees - GuruFocus

Apr 11, 2025

Apr 11, 2025

Summit Therapeutics (SMMT) Shows Resilient Cash Management Amid Challenges - GuruFocus

Apr 11, 2025

Apr 11, 2025

Why Summit Therapeutics Inc. (SMMT) Went Up On Thursday? - Insider Monkey

Apr 11, 2025

Apr 11, 2025

Truist maintains Buy on Summit Therapeutics, $35 target By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

10 Firms Buck Thursday’s Market Bloodbath - Insider Monkey

Apr 11, 2025

Apr 10, 2025

Summit Therapeutics (SMMT) Shares Surge After Insider Actions - GuruFocus

Apr 10, 2025

Apr 10, 2025

Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - MSN

Apr 10, 2025

Apr 10, 2025

Summit Therapeutics (SMMT) Sees Stock Surge Amid Early Warrant E - GuruFocus

Apr 10, 2025

Apr 10, 2025

Summit Therapeutics Shares Surge Amid Study Optimism - TipRanks

Apr 10, 2025

Apr 10, 2025

Summit Therapeutics (SMMT) Expected to Deliver Strong Results fr - GuruFocus

Apr 10, 2025

Apr 10, 2025

Summit Therapeutics (SMMT) Sees Bullish Surge as Co-CEO Exercise - GuruFocus

Apr 10, 2025

Apr 10, 2025

Summit Therapeutics stock gains on insider buy (SMMT:NASDAQ) - Seeking Alpha

Apr 10, 2025

Apr 10, 2025

Truist maintains Buy on Summit Therapeutics, $35 target - Investing.com

Apr 10, 2025

Apr 10, 2025

Cantor Fitzgerald maintains Overweight on Summit Therapeutics - Investing.com

Apr 10, 2025

Apr 09, 2025

Summit Therapeutics Co-CEOs Make Bold Stock Purchases! - TipRanks

Apr 09, 2025

Apr 07, 2025

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance

Apr 07, 2025

Apr 07, 2025

Optimistic Buy Rating for Summit Therapeutics Driven by Promising HARMONi-2 Trial and Favorable Regulatory Pathway in China - TipRanks

Apr 07, 2025

Apr 06, 2025

2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade - Yahoo Finance

Apr 06, 2025

Apr 05, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Summit Therapeutics Inc.SMMT - MarketScreener

Apr 05, 2025

Apr 05, 2025

We Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business Growth - Yahoo Finance

Apr 05, 2025

Apr 04, 2025

(SMMT) Technical Data - news.stocktradersdaily.com

Apr 04, 2025

Apr 04, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 04, 2025

Apr 04, 2025

Summit Therapeutics Agrees to $127K Settlement in Wage Dispute - USA Herald

Apr 04, 2025

Apr 04, 2025

Summit Therapeutics Strengthens Team with Strategic Stock Options Worth $3.4M - Stock Titan

Apr 04, 2025

Apr 03, 2025

Esperion Therapeutics (ESPR) Down 15.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Summit Therapeutics (SMMT) Surpasses Nvidia with High Hopes for Cancer Drug - GuruFocus

Apr 03, 2025

Apr 03, 2025

3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months - Yahoo Finance

Apr 03, 2025

Mar 31, 2025

Chinese Biotech Eyes US Nod for Cancer Therapy Eluding Merck - Bloomberg.com

Mar 31, 2025

Mar 31, 2025

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today - Yahoo Finance

Mar 31, 2025

Mar 29, 2025

Virtu Financial LLC Cuts Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report? - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

Summit Therapeutics: Major Upcoming Ivonescimab Data Catalyst May Not Be All It Seems (Rating Downgrade) - Seeking Alpha

Mar 28, 2025

Mar 26, 2025

Why Summit Therapeutics Stock Slipped Today - MSN

Mar 26, 2025